Chapter 3: Pharmacokinetics & Pharmacodynamics Fundamentals

Pharmacokinetics, often described as what the body does to a drug, involves the critical sequence of absorption, distribution, metabolism, and excretion. The discussion begins with the absorption process, detailing how substances enter the bloodstream through mechanisms like passive diffusion, facilitated transport, and active energy-requiring processes, while emphasizing the impact of first-pass metabolism in the liver which significantly reduces the bioavailability of oral medications. Factors such as gastric pH, the presence of food, and the use of enteric coatings or excipients further influence how quickly a drug reaches systemic circulation. Once absorbed, drugs are distributed through the plasma, where the concept of protein binding becomes paramount; only free drugs remain active to reach target tissues, while those bound to proteins like albumin remain inactive. This phase also highlights physiological safeguards such as the blood-brain barrier and placental membranes. Metabolism, or biotransformation, primarily occurs in the liver via the cytochrome P450 enzyme system, converting lipid-soluble agents into water-soluble metabolites for eventual removal. Key clinical concepts addressed include drug half-life, the attainment of steady-state concentrations, and the strategic use of loading doses for medications with prolonged elimination times. The pharmacokinetic cycle concludes with excretion, largely handled by the kidneys, where factors like glomerular filtration rate and urine alkalinity determine the rate of drug clearance. The focus then shifts to pharmacodynamics, or what a drug does to the body, centering on receptor theory and the dose-response relationship. It categorizes drugs as agonists that trigger physiological responses, antagonists that block them, or partial agonists that elicit moderate activity. The chapter explains the importance of the therapeutic index, noting that drugs with a narrow window between efficacy and toxicity require rigorous therapeutic drug monitoring through peak and trough level analysis. Timing is also essential, encompassing the onset of action, peak concentration, and total duration of effect. Furthermore, the summary delves into the complexities of drug interactions, distinguishing between additive effects, synergistic potentiation, and antagonistic interference. It addresses safety concerns including side effects, adverse reactions like anaphylaxis, and the development of drug tolerance or tachyphylaxis. Finally, the role of the nurse is emphasized through the clinical judgment measurement model, focusing on patient assessment, the identification of drug-nutrient interactions—such as the risk of hypertensive crisis with MAOIs and tyramine—and the management of drug-induced photosensitivity. This educational overview serves as a professional guide for understanding the clinical and biological intricacies of pharmaceutical therapy within a nursing framework.